Dysregulation of RNA interference components in COVID-19 patients
- PMID: 34715923
- PMCID: PMC8554738
- DOI: 10.1186/s13104-021-05816-0
Dysregulation of RNA interference components in COVID-19 patients
Abstract
Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the novel coronavirus causing severe respiratory illness (COVID-19). This virus was initially identified in Wuhan city, a populated area of the Hubei province in China, and still remains one of the major global health challenges. RNA interference (RNAi) is a mechanism of post-transcriptional gene silencing that plays a crucial role in innate viral defense mechanisms by inhibiting the virus replication as well as expression of various viral proteins. Dicer, Drosha, Ago2, and DGCR8 are essential components of the RNAi system, which is supposed to be dysregulated in COVID-19 patients. This study aimed to assess the expression level of the mentioned mRNAs in COVID-19patients compared to healthy individuals.
Results: Our findings demonstrated that the expression of Dicer, Drosha, and Ago2 was statistically altered in COVID-19 patients compared to healthy subjects. Ultimately, the RNA interference mechanism as a crucial antiviral defense system was suggested to be dysregulated in COVID-19 patients.
Keywords: Ago2; DGCR8; Dicer; Drosha; RNA interference; SARS-CoV-2.
© 2021. The Author(s).
Conflict of interest statement
The author declares no conflict of interest.
Figures



Similar articles
-
Genes Involved in miRNA Biogenesis Are Not Downregulated in SARS-CoV-2 Infection.Viruses. 2023 May 16;15(5):1177. doi: 10.3390/v15051177. Viruses. 2023. PMID: 37243263 Free PMC article.
-
The RNA Interference Effector Protein Argonaute 2 Functions as a Restriction Factor Against SARS-CoV-2.J Mol Biol. 2023 Aug 15;435(16):168170. doi: 10.1016/j.jmb.2023.168170. Epub 2023 Jun 3. J Mol Biol. 2023. PMID: 37271493 Free PMC article.
-
Drosha, DGCR8, and Dicer mRNAs are down-regulated in human cells infected with dengue virus 4, and play a role in viral pathogenesis.Genet Mol Res. 2016 May 9;15(2). doi: 10.4238/gmr.15027891. Genet Mol Res. 2016. PMID: 27173348
-
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26. Drug Resist Updat. 2020. PMID: 33132205 Free PMC article. Review.
-
Antiviral innate immune response of RNA interference.J Infect Dev Ctries. 2014 Jul 14;8(7):804-10. doi: 10.3855/jidc.4187. J Infect Dev Ctries. 2014. PMID: 25022288 Review.
Cited by
-
Nuclear AGO2 supports influenza A virus replication through type-I interferon regulation.Nucleic Acids Res. 2025 Apr 10;53(7):gkaf268. doi: 10.1093/nar/gkaf268. Nucleic Acids Res. 2025. PMID: 40219968 Free PMC article.
-
Host tRNA-Derived RNAs Target the 3'Untranslated Region of SARS-CoV-2.Pathogens. 2022 Dec 6;11(12):1479. doi: 10.3390/pathogens11121479. Pathogens. 2022. PMID: 36558813 Free PMC article.
-
Genes Involved in miRNA Biogenesis Are Not Downregulated in SARS-CoV-2 Infection.Viruses. 2023 May 16;15(5):1177. doi: 10.3390/v15051177. Viruses. 2023. PMID: 37243263 Free PMC article.
-
Processing of genomic RNAs by Dicer in bat cells limits SARS-CoV-2 replication.Virol J. 2025 Mar 25;22(1):86. doi: 10.1186/s12985-025-02693-y. Virol J. 2025. PMID: 40133950 Free PMC article.
-
Macrophage Activation Syndrome in Coinciding Pandemics of Obesity and COVID-19: Worse than Bad.Adv Exp Med Biol. 2024;1460:919-954. doi: 10.1007/978-3-031-63657-8_31. Adv Exp Med Biol. 2024. PMID: 39287877 Review.
References
-
- Kumar S, Nyodu R, Maurya VK, Saxena SK. Morphology, genome organization, replication, and pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Coronavirus Disease 2019 (COVID-19) Springer; 2020. pp. 23–31.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous